Join
us October 1-4, 2009 at the Fairmont Chicago
Register Now
If
your clinical practice or scientific focus includes
patients with breast cancer, the 11th Annual Lynn Sage
Breast Cancer Symposium is the annual opportunity to
learn about new advances and discuss your own experiences.
It is an unrivaled opportunity to collaborate with your
esteemed colleagues and meet some of the top innovators
in these fields.
Attended by a growing roster of experts from around
the world, the Lynn Sage Breast Cancer Symposium will
consist of panels and presentations on practical patient
strategies, as well as exciting possibilities from the
world of research. Join radiologists, oncologists, surgeons,
gynecologists, family practitioners and geneticists
involved in the care of women with breast cancer.
Program Description
An
annual conference targeting individuals actively engaged
clinically or scientifically in diagnostic and therapeutic
radiology, oncology, surgery, gynecology, family practice
and genetics.
The optimal management of breast
cancer is rapidly evolving. A multidisciplinary team
of medical, surgical and radiation oncologists, pathologists,
plastic surgeons and genetic counselors are routinely
involved in offering treatment recommendations for individual
patients with a diagnosis of breast cancer. With the
emergence of prevention strategies, women at high risk
of developing breast cancer are now evaluated for medical
therapies, surgical options and lifestyle changes that
may reduce their risk of developing breast cancer. The
11th Annual Lynn Sage Breast Cancer Symposium provides
a forum for discussing and presenting laboratory and
clinical research concerning the care of patients with
breast cancer.
Educational Objectives
At
the conclusion of this symposium participants should
be able to:
1. Explain the importance of communication skills as
a means of discussing recurrence risk and conveying
bad news to patients.
2. Cite different variants of breast cancer and their
associated clinical implications.
3. Identify the controversies surrounding the use of
breast MRI for surgical management of early stage breast
cancer.
4. Describe the evolving role of genomic profiling for
management of early stage breast cancer.
5. Analyze treatment strategies for treating triple-negative
breast.
6. Discuss the adjuvant radiation therapy options for
women with early stage breast cancer.
7. Describe the optimal use of endocrine therapy in
the adjuvant treatment of breast cancer.
8. Describe novel systemic therapy for the treatment
of inflammatory and metastatic breast cancer.
|
